C4 Therapeutics Inc

NASDAQ:CCCC   9:49:39 AM EDT
35.65
+1.36 (+3.97%)
Earnings Announcements

C4 Therapeutics Reports Q3 2020 Financial Results

Published: 11/12/2020 21:33 GMT
(CCCC) - C4 Therapeutics Reports Business Highlights and Third Quarter 2020 Financial Results.
Q3 Revenue $8.4 Million Versus $5.4 Million.
Qtrly Loss per Share $17.55.
Revenue is expected to be $7.7 Million
Adjusted EPS is expected to be -$0.54

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.